APA   Click to copy
D'Angelo, A., Giudici, F., Chapman, R., Darlow, J., Kilili, H., Sobhani, N., … Generali, D. (2022). Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study. Current Issues Molecular Biology, 44(9), 4255–4267. https://doi.org/10.3390/cimb44090292.

Chicago/Turabian   Click to copy
D'Angelo, Alberto, Fabiola Giudici, Robert Chapman, Jacob Darlow, Huseyin Kilili, Navid Sobhani, Mattia Cinelli, et al. “Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study.” Current Issues Molecular Biology 44, no. 9 (2022): 4255–4267.

MLA   Click to copy
D'Angelo, Alberto, et al. “Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study.” Current Issues Molecular Biology, vol. 44, no. 9, 2022, pp. 4255–67, doi:10.3390/cimb44090292.

@article{alberto2022a,
  title = {Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study},
  year = {2022},
  issue = {9},
  journal = {Current Issues Molecular Biology},
  pages = {4255-4267},
  volume = {44},
  doi = {10.3390/cimb44090292.},
  author = {D'Angelo, Alberto and Giudici, Fabiola and Chapman, Robert and Darlow, Jacob and Kilili, Huseyin and Sobhani, Navid and Cinelli, Mattia and Cappelletti, Maria Rosa and Strina, Carla and Milani, Manuela and Generali, Daniele}
}